Physician

Alexander Paul Boardman, MD

According to 2025 Medicare claims, Alexander Boardman, MD (NPI: 1588194286) practices medical oncology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from New York, NY. This provider's primary affiliated billing organization is MEMORIAL HEMATOLOGY LYMPHOMA GROUP (NPI: 1891766366; TIN: 133278575) and primary practice location at 10021-3402.

Boardman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 119 traditional Medicare patients, billed 405 HCPCS/CPT codes, and received $40,461 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 387 prescription claims across 41 beneficiaries totaling $880,626 in drug costs, led by Brukinsa (Zanubrutinib). Open Payments data shows 9 records totaling $77,339. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $5,956 to $880,626. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$20K$40K2023 Medicare payment: $22,603 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $40,461 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
202371234$22,603
2024119405$40,461

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$440K$881K2017 Drug cost: $5,956 (USD; Tot_Drug_Cst)2018 Drug cost: $42,635 (USD; Tot_Drug_Cst)2019 Drug cost: $55,165 (USD; Tot_Drug_Cst)2020 Drug cost: $63,118 (USD; Tot_Drug_Cst)2021 Drug cost: $7,128 (USD; Tot_Drug_Cst)2022 Drug cost: $4,245 (USD; Tot_Drug_Cst)2023 Drug cost: $94,000 (USD; Tot_Drug_Cst)2024 Drug cost: $880,626 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
201723110$5,956
201847450$42,635
201947453$55,165
202035216$63,118
20212758$7,128
2022N/R30$4,245
20232278$94,000
202441387$880,626

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more3333$159
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more3566$125
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes2083$102
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more55122$86
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1526$57

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BrukinsaZanubrutinib33990$460,144
AcyclovirAcyclovir1013,575$1,201
EntecavirEntecavir22660$826
Pantoprazole SodiumPantoprazole Sodium361,080$234
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim27842$107

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$4,325E.R. Squibb & Sons, L.L.C.
Research PaymentsReported research-related payment or transfer-of-value amount.5$73,014ABBVIE INC.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alexander Paul Boardman, MD?

Tedicare shows public-source Medicare data for Alexander Paul Boardman, MD (NPI 1588194286), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexander Paul Boardman, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alexander Paul Boardman, MD?

Alexander Paul Boardman, MD is linked to MEMORIAL HEMATOLOGY LYMPHOMA GROUP (billing NPI 1891766366) in the available physician profile data.

Does Alexander Paul Boardman, MD have Open Payments data?

Alexander Paul Boardman, MD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.